Skip to main content

Table 3 Distribution of genotype and allele frequencies of VDR variants in controls, cases and patient subgroups

From: Vitamin D receptor ApaI polymorphism associated with progression of liver disease in Vietnamese patients chronically infected with hepatitis B virus

VDR polymorphisms

Genotype frequency

n, (%)

P*

Allele frequency

n, (%)

P*

Comparisons

ApaI (rs7975232)

CC

AC

AA

 

C

A

  

 Controls

114

(48.7)

106

(45.3)

14

(6)

NS

334

(71.4)

134

(28.6)

NS

Cases vs. controls

 Cases

203

(47.8)

183

(43.2)

38

(9)

589

(70)

259

(30)

 CHB

76

(42.2)

94

(52.2)

10

(5.6)

NS

246

(68.3)

114

(31.7)

NS

LC vs. CHB

 LC

41

(50.6)

32

(39.5)

8

(9.9)

NS

114

(70.3)

48

(29.7)

NS

HCC vs. LC

 HCC

86

(52.8)

57

(35)

20

(12.3)

0.0022

229

(70.2)

97

(29.8)

NS

HCC vs. CHB

 non-HCC

117

(44.8)

126

(48.3)

18

(6.9)

0.013

360

(69)

162

(31)

NS

HCC vs. Non-HCC

FokI (rs2228570)

GG

 

GA

 

AA

  

G

 

A

   

 Controls

49

(23)

116

(54.5)

48

(22.5)

NS

214

(50.2)

212

(49.8)

NS

Cases vs. controls

 Cases

108

(25)

233

(54)

91

(21)

449

(52)

415

(48)

 CHB

49

(27.8)

91

(51.7)

36

(20.5)

NS

189

(53.7)

163

(46.3)

NS

LC vs. CHB

 LC

12

(15.4)

47

(60.3)

19

(24.3)

NS

71

(45.5)

85

(55.5)

NS

HCC vs. LC

 HCC

47

(26.4)

95

(53.4)

36

(20.2)

NS

189

(53)

167

(47)

NS

HCC vs. CHB

 non-HCC

61

(24)

138

(54.3)

55

(21.7)

NS

260

(51.2)

248

(48.8)

NS

HCC vs. Non-HCC

TaqI (rs731236)

TT

 

TC

 

CC

  

T

 

C

   

 Controls

177

(90.8)

18

(9.2)

0

(0)

NS

372

(95.4)

18

(4.6)

NS

Cases vs. controls

 Cases

423

(91.4)

40

(8.6)

0

(0)

886

(95.7)

40

(4.3)

 CHB

168

(92.3)

14

(7.7)

0

(0)

NS

350

(96.2)

14

(3.8)

NS

LC vs. CHB

 LC

81

(91.1)

8

(8.9)

0

(0)

NS

170

(95.5)

8

(4.5)

NS

HCC vs. LC

 HCC

174

(90.6)

18

(9.4)

0

(0)

NS

366

(95.4)

18

(4.6)

NS

HCC vs. CHB

 non-HCC

249

(91.9)

22

(8.1)

0

(0)

NS

520

(96)

22

(4)

NS

HCC vs. Non-HCC

BsmI (rs1544410)

CC

 

CT

 

TT

  

C

 

T

   

 Controls

196

(92.5)

16

(7.5)

0

(0)

NS

408

(96.2)

16

(3.8)

NS

Cases vs. controls

 Cases

404

(94)

26

(6.0)

0

(0)

838

(97)

26

(3)

 

 CHB

162

(92.6)

13

(7.4)

0

(0)

NS

337

(96.3)

13

(3.7)

NS

LC vs. CHB

 LC

71

(93.4)

5

(6.6)

0

(0)

NS

147

(96.7)

5

(3.3)

NS

HCC vs. LC

 HCC

171

(95.6)

8

(4.4)

0

(0)

NS

350

(97.7)

8

(2.3)

NS

HCC vs. CHB

 non-HCC

233

(92.8)

18

(7.2)

0

(0)

NS

484

(96.4)

18

(3.6)

NS

HCC vs. Non-HCC

  1. CHB chronic hepatitis B, LC liver cirrhosis, HCC hepatocellular carcinoma; Cases = all HBV infected patients; non-HCC, CHB + LC, n = number of chromosomes; OR adjusted Odds Ratio, NS not significant, (*) Chi squared test